Wikipedia:Articles for deletion/ADC Review / Journal of Antibody Drug Conjugates


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was   delete. Mark Arsten (talk) 03:25, 7 July 2013 (UTC)

ADC Review / Journal of Antibody Drug Conjugates

 * – ( View AfD View log  Stats )

New journal, has not yet had time to become notable. Article creation vastly premature. No independent references, not included in any selective major databases. Does not meet WP:GNG or WP:NJournals. Randykitty (talk) 08:00, 30 June 2013 (UTC)
 * Delete. As far as I can see, the journal has not yet published a single research article so it cannot meet any of the criteria at WP:NJOURNALS. The article can always be recreated in the future, if the criteria are met. Dricherby (talk) 10:58, 30 June 2013 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions. • Gene93k (talk) 18:15, 30 June 2013 (UTC)


 * Delete. This is obviously way too soon and spectacularly fails WP:NJournals. It hasn't published a single peer-reviewed article of its own yet. Its "advisory board" is largely made up of employees/researchers for pharmaceutical companies. Its sponsors are two pharmaceutical companies and its publisher, Impress Labs, describes its business as: "Brand development, creative expression, and well-executed communication strategies." The editor of this journal is also the Managing Partner of Impress Labs. If this company's journal ever takes off, it might achieve notability in a few years' time as an innovative marketing strategy for drug companies, but I rather doubt that it will achieve it as a scholarly journal. In any case, it doesn't belong here now. Voceditenore (talk) 15:04, 1 July 2013 (UTC)
 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.